Terms: = Uterine cancer AND TFE3, RCCP2, 7030, ENSG00000068323, TFEA
35 results:
1. Clinicopathological features of two ultra-rare cases of malignant perivascular epithelioid cell tumors (PEComas) involving the uterus with recent updates.
Rekhi B; Menon S
Indian J Pathol Microbiol; 2024; 67(1):137-140. PubMed ID: 38358203
[TBL] [Abstract] [Full Text] [Related]
2. PKM2 controls the translation of tfe3 to maintain the integrity of the Golgi apparatus for the survival of HeLa and ME-180 cervical cancer cells.
Taguchi Y; Ito K; Kano F
FEBS J; 2023 Jun; 290(12):3221-3242. PubMed ID: 36705569
[TBL] [Abstract] [Full Text] [Related]
3. Perivascular epithelioid cell tumor of the uterine cervix identified on the liquid-based cytology: a case report.
Tang X; Feng M; Shen Y; Chen Q
Diagn Pathol; 2023 Jan; 18(1):7. PubMed ID: 36647157
[TBL] [Abstract] [Full Text] [Related]
4. Malignant Perivascular Epithelioid Cell Tumor (PEComa) of the Uterus as Part of the Hereditary cancer Syndrome: A Case Diagnosed with Multiple Malignancies.
Caliskan S; Akar OS; Gun S; Kefeli M
Turk Patoloji Derg; 2023; 39(3):212-217. PubMed ID: 36367123
[TBL] [Abstract] [Full Text] [Related]
5. [Endometrial and other rare uterine sarcomas : Diagnostic aspects in the context of the 2020 WHO classification].
Mayr D; Horn LC; Hiller GGR; Höhn AK; Schmoeckel E
Pathologe; 2022 May; 43(3):183-195. PubMed ID: 35362728
[TBL] [Abstract] [Full Text] [Related]
6. tfe3-associated perivascular epithelioid cell tumor with complete response to mTOR inhibitor therapy: report of first case and literature review.
Purwar R; Soni K; Shukla M; Verma A; Kumar T; Pandey M
World J Surg Oncol; 2022 Mar; 20(1):62. PubMed ID: 35232443
[TBL] [Abstract] [Full Text] [Related]
7. Formononetin represses cervical tumorigenesis by interfering with the activation of PD-L1 through MYC and STAT3 downregulation.
Wang JY; Jiang MW; Li MY; Zhang ZH; Xing Y; Ri M; Jin CH; Xu GH; Piao LX; Jin HL; Ma J; Jin Y; Zuo HX; Jin X
J Nutr Biochem; 2022 Feb; 100():108899. PubMed ID: 34748924
[TBL] [Abstract] [Full Text] [Related]
8. A novel attention-guided convolutional network for the detection of abnormal cervical cells in cervical cancer screening.
Cao L; Yang J; Rong Z; Li L; Xia B; You C; Lou G; Jiang L; Du C; Meng H; Wang W; Wang M; Li K; Hou Y
Med Image Anal; 2021 Oct; 73():102197. PubMed ID: 34403932
[TBL] [Abstract] [Full Text] [Related]
9. [Clinicopathological features and prognosis of fumarate hydratase deficient renal cell carcinoma].
Yu YF; He SM; Wu YC; Xiong SW; Shen Q; Li YY; Yang F; He Q; Li XS
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 53(4):640-646. PubMed ID: 34393221
[TBL] [Abstract] [Full Text] [Related]
10. uterine PEComas: correlation between melanocytic marker expression and TSC alterations/tfe3 fusions.
Bennett JA; Ordulu Z; Pinto A; Wanjari P; Antonescu CR; Ritterhouse LL; Oliva E
Mod Pathol; 2022 Apr; 35(4):515-523. PubMed ID: 34131293
[TBL] [Abstract] [Full Text] [Related]
11. Alveolar Soft Part Sarcoma of uterine Corpus in a Young Female: A Case Report With Review of Literature.
Vishwajeet V; Elhence P; Singh P; Ghuman NK
Int J Gynecol Pathol; 2021 May; 40(3):272-277. PubMed ID: 33323848
[TBL] [Abstract] [Full Text] [Related]
12. uterine plexiform tumourlets: multifocal and solitary cases with subsets expressing melanocytic markers.
Stewart CJR; McCluggage WG; Chua YJ; Texler M; Rabban JT
Histopathology; 2021 Apr; 78(5):690-698. PubMed ID: 33103268
[TBL] [Abstract] [Full Text] [Related]
13. Fumarate hydratase-deficient renal cell carcinoma: A clinicopathological study of seven cases including hereditary and sporadic forms.
Kuroda N; Tsutsui M; Iguchi M; Nobuoka E; Uehara T; Sonobe Y; Morinaga Y; Shibuya S; Oda W; Yanai H; Kawada C; Karashima T; Yamasaki I; Inoue K; Nagashima Y
Ann Diagn Pathol; 2020 Dec; 49():151599. PubMed ID: 32977234
[TBL] [Abstract] [Full Text] [Related]
14. Genomic Profiling Aids Classification of Diagnostically Challenging uterine Mesenchymal Tumors With Myomelanocytic Differentiation.
Selenica P; Conlon N; Gonzalez C; Frosina D; Jungbluth AA; Beets-Tan RGH; Rao MK; Zhang Y; Benayed R; Ladanyi M; Solit DB; Chiang S; Hyman DM; Hensley ML; Soslow RA; Weigelt B; Murali R
Am J Surg Pathol; 2021 Jan; 45(1):77-92. PubMed ID: 32889887
[TBL] [Abstract] [Full Text] [Related]
15. Gene of the month: TFE 3.
Pinto K; Chetty R
J Clin Pathol; 2020 Nov; 73(11):691-694. PubMed ID: 32820043
[TBL] [Abstract] [Full Text] [Related]
16. Plasma growth differentiation factor-15 is an independent marker for aggressive disease in endometrial cancer.
Engerud H; Hope K; Berg HF; Fasmer KE; Tangen IL; Haldorsen IS; Trovik J; Krakstad C
PLoS One; 2019; 14(1):e0210585. PubMed ID: 30645608
[TBL] [Abstract] [Full Text] [Related]
17. Making the invisible visible: improving detectability of MRI-invisible residual cervical cancer after conisation by DCE-MRI.
Huang JW; Song JC; Chen T; Yang M; Ma ZL
Clin Radiol; 2019 Feb; 74(2):166.e15-166.e21. PubMed ID: 30503642
[TBL] [Abstract] [Full Text] [Related]
18. uterine PEComas: A Morphologic, Immunohistochemical, and Molecular Analysis of 32 Tumors.
Bennett JA; Braga AC; Pinto A; Van de Vijver K; Cornejo K; Pesci A; Zhang L; Morales-Oyarvide V; Kiyokawa T; Zannoni GF; Carlson J; Slavik T; Tornos C; Antonescu CR; Oliva E
Am J Surg Pathol; 2018 Oct; 42(10):1370-1383. PubMed ID: 30001237
[TBL] [Abstract] [Full Text] [Related]
19. Clinicopathological Characteristics of Ovarian Sclerosing Stromal Tumor with an Emphasis on tfe3 Overexpression.
Park CK; Kim HS
Anticancer Res; 2017 Oct; 37(10):5441-5447. PubMed ID: 28982854
[TBL] [Abstract] [Full Text] [Related]
20. Alveolar Soft Part Sarcoma of the Female Genital Tract: A Morphologic, Immunohistochemical, and Molecular Cytogenetic Study of 10 Cases With Emphasis on its Distinction From Morphologic Mimics.
Schoolmeester JK; Carlson J; Keeney GL; Fritchie KJ; Oliva E; Young RH; Nucci MR
Am J Surg Pathol; 2017 May; 41(5):622-632. PubMed ID: 28009610
[TBL] [Abstract] [Full Text] [Related]
[Next]
